Statute Details
- Title: Medicines (Cessation of Application of Act to Medical Devices) Order 2010
- Act Code: MA1975-S439-2010
- Type: Subsidiary Legislation (SL)
- Authorising Act: Medicines Act (Cap. 176), specifically section 77
- Legislative Instrument No.: S 439/2010
- Date Made: 5 August 2010
- Commencement: 10 August 2010
- Status: Current version as at 27 March 2026
- Key Provisions: Sections 1–3 (citation/commencement; definition; cessation of application)
- Definition Anchor: “medical device” is tied to the First Schedule to the Health Products Act (Cap. 122D)
What Is This Legislation About?
The Medicines (Cessation of Application of Act to Medical Devices) Order 2010 is a short but legally significant instrument. In plain terms, it marks a regulatory boundary change: it stops the Medicines Act from applying to medical devices as of 10 August 2010.
Before this Order took effect, medical devices were, at least in part, subject to the Medicines Act framework. The Order reflects a policy and legislative shift towards a more specialised regulatory regime for health products. In Singapore, medical devices are now regulated under the Health Products Act (Cap. 122D), which contains its own definitions, classifications, and regulatory mechanisms.
Practically, the Order ensures that there is no overlap or confusion about which legal regime governs medical devices. By expressly “ceasing” the application of the Medicines Act to medical devices, it reduces regulatory uncertainty for manufacturers, importers, distributors, and healthcare stakeholders who need to know which approvals, licensing requirements, and compliance obligations apply.
What Are the Key Provisions?
Section 1 (Citation and commencement). This section provides the formal name of the Order and states when it comes into operation. The Order may be cited as the Medicines (Cessation of Application of Act to Medical Devices) Order 2010 and it commenced on 10 August 2010. For practitioners, the commencement date is crucial because it determines the point at which the Medicines Act stops applying to medical devices and the Health Products Act regime becomes the relevant legal framework.
Section 2 (Definition). The Order defines “medical device” by reference to another statute: it means a medical device “referred to in the First Schedule to the Health Products Act (Cap. 122D).” This cross-reference is legally important. It means the scope of the Order is not limited to a narrow description in the Order itself; instead, it tracks the classification approach in the Health Products Act’s First Schedule.
From a legal interpretation standpoint, this drafting technique has two consequences. First, the meaning of “medical device” for the purpose of cessation is anchored to the Health Products Act schedule, which may be amended over time. Second, the cessation is therefore aligned with the Health Products Act’s regulatory taxonomy—ensuring that devices that fall within the schedule are treated consistently across the regulatory system.
Section 3 (Cessation of application of Act). This is the operative provision. It states that “the provisions of the Act shall cease to apply to any medical device as from 10th August 2010.” The “Act” in context refers to the Medicines Act (Cap. 176). The effect is sweeping: it is not limited to particular sections of the Medicines Act; rather, it stops the Medicines Act provisions from applying to medical devices altogether from the commencement date.
For practitioners, the key legal question is what “cease to apply” means in practice. Generally, it indicates that the Medicines Act no longer governs medical devices going forward. This affects compliance obligations (for example, whether a particular activity requires a Medicines Act licence/approval versus a Health Products Act authorisation), enforcement pathways, and potentially the regulatory status of products in the market.
Because the Order is explicit and time-bound, it also supports a clear transition analysis. If a product is a “medical device” within the First Schedule to the Health Products Act, then after 10 August 2010, the Medicines Act is not the controlling statute for that product. Any regulatory steps taken after that date should be assessed under the Health Products Act framework.
How Is This Legislation Structured?
This Order is structured in a straightforward three-section format:
Section 1 deals with citation and commencement, setting the effective date.
Section 2 provides a definition of “medical device” by cross-reference to the First Schedule of the Health Products Act.
Section 3 contains the core legal effect: the cessation of application of the Medicines Act to medical devices from the commencement date.
There are no schedules, no detailed regulatory procedures, and no transitional provisions in the text provided. The instrument’s function is therefore primarily “jurisdictional” and “regime-switching”: it changes which Act applies to a category of regulated products.
Who Does This Legislation Apply To?
The Order applies to medical devices as defined by reference to the First Schedule to the Health Products Act. While the Order does not list specific persons (such as manufacturers, importers, or distributors), those persons are the practical stakeholders affected because they must comply with the applicable regulatory regime for the products they handle.
In other words, the legal effect is product-based rather than person-based. If a product qualifies as a “medical device” under the Health Products Act schedule, then from 10 August 2010 the Medicines Act provisions cease to apply to that product. Accordingly, compliance and enforcement relating to that product should be assessed under the Health Products Act (and any subsidiary legislation made under it), rather than under the Medicines Act.
Why Is This Legislation Important?
Although the Order is brief, it is important because it clarifies regulatory jurisdiction. In healthcare regulation, the difference between “medicine” and “medical device” can determine the licensing pathway, the documentation required, the standards applied, and the enforcement authority’s approach. By formally ceasing the Medicines Act’s application to medical devices, the Order helps prevent regulatory overlap and reduces the risk of non-compliance caused by uncertainty about which Act governs.
For legal practitioners, the Order is also useful as a reference point in disputes or compliance reviews. For example, if a client’s product was assessed under the Medicines Act after 10 August 2010, the Order supports an argument that such an assessment was legally misdirected for medical devices. Conversely, if a client is attempting to rely on Medicines Act processes for a device, the Order indicates that those processes should not be treated as the correct legal basis after the commencement date.
Finally, the Order demonstrates a common legislative technique in Singapore’s regulatory framework: using subsidiary legislation to effect a clean transition between regimes. The cross-reference to the Health Products Act schedule ensures that the cessation aligns with the established classification of medical devices. This alignment is critical for consistency across the regulatory system and for maintaining a coherent legal basis for approvals and compliance obligations.
Related Legislation
- Health Products Act (Cap. 122D) — including the First Schedule defining “medical device” categories
- Medicines Act (Cap. 176) — the Act whose provisions cease to apply to medical devices under this Order
- Medicines (Cessation of Application of Act to Medical Devices) Order 2010 — S 439/2010 (this instrument)
Source Documents
This article provides an overview of the Medicines (Cessation of Application of Act to Medical Devices) Order 2010 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the official text for authoritative provisions.